Crestwood Advisors Group LLC Has $31.41 Million Stock Holdings in Lam Research Corporation $LRCX

Crestwood Advisors Group LLC reduced its position in Lam Research Corporation (NASDAQ:LRCX) by 5.0% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 322,659 shares of the semiconductor company’s stock after selling 16,909 shares during the period. Crestwood Advisors Group LLC’s holdings in Lam Research were worth $31,408,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of LRCX. Vanguard Group Inc. increased its holdings in Lam Research by 6.9% in the first quarter. Vanguard Group Inc. now owns 129,152,102 shares of the semiconductor company’s stock worth $9,389,358,000 after buying an additional 8,364,375 shares during the last quarter. Nuveen LLC acquired a new position in Lam Research in the first quarter worth approximately $604,344,000. Price T Rowe Associates Inc. MD increased its holdings in Lam Research by 99.7% in the first quarter. Price T Rowe Associates Inc. MD now owns 5,739,221 shares of the semiconductor company’s stock worth $417,242,000 after buying an additional 2,864,863 shares during the last quarter. Nordea Investment Management AB increased its stake in shares of Lam Research by 34.1% during the 2nd quarter. Nordea Investment Management AB now owns 10,594,574 shares of the semiconductor company’s stock worth $1,029,210,000 after purchasing an additional 2,692,189 shares during the last quarter. Finally, Boston Partners increased its stake in shares of Lam Research by 9,978.3% during the 1st quarter. Boston Partners now owns 2,350,362 shares of the semiconductor company’s stock worth $170,787,000 after purchasing an additional 2,327,041 shares during the last quarter. 84.61% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Lam Research

In other news, SVP Vahid Vahedi sold 52,190 shares of the firm’s stock in a transaction on Monday, October 13th. The shares were sold at an average price of $138.90, for a total value of $7,249,191.00. Following the sale, the senior vice president owned 251,047 shares in the company, valued at approximately $34,870,428.30. This trade represents a 17.21% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Ava Harter sold 9,010 shares of the firm’s stock in a transaction on Monday, October 27th. The stock was sold at an average price of $157.47, for a total transaction of $1,418,804.70. Following the completion of the sale, the insider owned 56,786 shares in the company, valued at $8,942,091.42. This represents a 13.69% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders have sold 62,498 shares of company stock worth $8,875,663. Insiders own 0.31% of the company’s stock.

Wall Street Analyst Weigh In

LRCX has been the topic of several analyst reports. Argus increased their price target on shares of Lam Research from $105.00 to $120.00 and gave the stock a “buy” rating in a research note on Friday, August 1st. Erste Group Bank initiated coverage on shares of Lam Research in a research report on Thursday, August 14th. They set a “buy” rating on the stock. BNP Paribas Exane increased their price objective on Lam Research from $80.00 to $140.00 and gave the company a “neutral” rating in a report on Thursday, October 23rd. Zacks Research raised Lam Research from a “hold” rating to a “strong-buy” rating in a report on Monday, October 20th. Finally, The Goldman Sachs Group increased their price objective on Lam Research from $115.00 to $160.00 and gave the company a “buy” rating in a report on Wednesday, October 8th. One research analyst has rated the stock with a Strong Buy rating, twenty-six have assigned a Buy rating and nine have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $148.54.

Lam Research Trading Down 3.4%

Shares of NASDAQ:LRCX opened at $155.78 on Wednesday. The company has a market cap of $195.66 billion, a P/E ratio of 34.31, a P/E/G ratio of 1.68 and a beta of 1.84. The stock’s 50-day moving average is $131.37 and its 200-day moving average is $104.82. Lam Research Corporation has a 52-week low of $56.32 and a 52-week high of $165.22. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.60 and a current ratio of 2.21.

Lam Research (NASDAQ:LRCX) last released its earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.22 by $0.04. The firm had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.23 billion. Lam Research had a return on equity of 60.60% and a net margin of 29.66%.The company’s revenue was up 27.7% on a year-over-year basis. During the same quarter last year, the firm posted $0.86 EPS. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. Equities research analysts predict that Lam Research Corporation will post 3.71 earnings per share for the current year.

Lam Research Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, October 15th. Stockholders of record on Wednesday, September 24th were paid a $0.26 dividend. The ex-dividend date was Wednesday, September 24th. This is a positive change from Lam Research’s previous quarterly dividend of $0.23. This represents a $1.04 annualized dividend and a dividend yield of 0.7%. Lam Research’s dividend payout ratio is 22.91%.

About Lam Research

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.